| Dr Jeffrey Alan Kohn, MD | |
|
1050 Clove Rd, Staten Island, NY 10301-3627 | |
| (718) 819-3710 | |
| (718) 816-3611 |
| Full Name | Dr Jeffrey Alan Kohn |
|---|---|
| Gender | Male |
| Speciality | Cardiovascular Disease (cardiology) |
| Experience | 21 Years |
| Location | 1050 Clove Rd, Staten Island, New York |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1235218918 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| New York University Langone Medical Center | New york, NY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| New York Medical Associates Pc | 8820989965 | 3 |
News Archive
ViroPharma Incorporated today announced that it has signed an agreement with Sanquin Blood Supply Foundation for rights to develop, file regulatory dossiers, and commercialize Cinryze(TM) (C1 esterase inhibitor [human]) for hereditary angioedema (HAE) as well as for potential new indications in certain European and rest of world (ROW) territories.
Cancer Research UK-funded scientists have taken a further step to identifying men at a greater risk of prostate cancer with the discovery of seven new variants in the human genome that increase the chances of developing the disease. The research is published in Nature Genetics.
Harvard scientists have solved the long-standing mystery of how some insects form the germ cells - the cellular precursors to the eggs and sperm necessary for sexual reproduction - and the answer is shedding new light on the evolutionary origins of a gene that had long been thought to be critical to the process.
Zealand Pharma, a biopharmaceutical company dedicated to the discovery and development of innovative peptide drugs that recently listed on NASDAQ OMX, today announces the receipt of a EUR 500,000 (DKK 3.73 million) milestone payment as part of its license agreement with Helsinn Healthcare for the development of ZP1846 for the treatment of chemotherapy-induced diarrhoea. This milestone payment has no impact on the Company's outlook for 2010.
Coronary heart disease is the leading cause of death in the U.S., and African Americans are disproportionately affected.
› Verified 1 days ago
| Entity Name | New York Medical Associates Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1649351271 PECOS PAC ID: 8820989965 Enrollment ID: O20050615001133 |
News Archive
ViroPharma Incorporated today announced that it has signed an agreement with Sanquin Blood Supply Foundation for rights to develop, file regulatory dossiers, and commercialize Cinryze(TM) (C1 esterase inhibitor [human]) for hereditary angioedema (HAE) as well as for potential new indications in certain European and rest of world (ROW) territories.
Cancer Research UK-funded scientists have taken a further step to identifying men at a greater risk of prostate cancer with the discovery of seven new variants in the human genome that increase the chances of developing the disease. The research is published in Nature Genetics.
Harvard scientists have solved the long-standing mystery of how some insects form the germ cells - the cellular precursors to the eggs and sperm necessary for sexual reproduction - and the answer is shedding new light on the evolutionary origins of a gene that had long been thought to be critical to the process.
Zealand Pharma, a biopharmaceutical company dedicated to the discovery and development of innovative peptide drugs that recently listed on NASDAQ OMX, today announces the receipt of a EUR 500,000 (DKK 3.73 million) milestone payment as part of its license agreement with Helsinn Healthcare for the development of ZP1846 for the treatment of chemotherapy-induced diarrhoea. This milestone payment has no impact on the Company's outlook for 2010.
Coronary heart disease is the leading cause of death in the U.S., and African Americans are disproportionately affected.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Jeffrey Alan Kohn, MD 2791 Richmond Ave, Suite 201, Staten Island, NY 10314-5882 Ph: (718) 816-3710 | Dr Jeffrey Alan Kohn, MD 1050 Clove Rd, Staten Island, NY 10301-3627 Ph: (718) 819-3710 |
News Archive
ViroPharma Incorporated today announced that it has signed an agreement with Sanquin Blood Supply Foundation for rights to develop, file regulatory dossiers, and commercialize Cinryze(TM) (C1 esterase inhibitor [human]) for hereditary angioedema (HAE) as well as for potential new indications in certain European and rest of world (ROW) territories.
Cancer Research UK-funded scientists have taken a further step to identifying men at a greater risk of prostate cancer with the discovery of seven new variants in the human genome that increase the chances of developing the disease. The research is published in Nature Genetics.
Harvard scientists have solved the long-standing mystery of how some insects form the germ cells - the cellular precursors to the eggs and sperm necessary for sexual reproduction - and the answer is shedding new light on the evolutionary origins of a gene that had long been thought to be critical to the process.
Zealand Pharma, a biopharmaceutical company dedicated to the discovery and development of innovative peptide drugs that recently listed on NASDAQ OMX, today announces the receipt of a EUR 500,000 (DKK 3.73 million) milestone payment as part of its license agreement with Helsinn Healthcare for the development of ZP1846 for the treatment of chemotherapy-induced diarrhoea. This milestone payment has no impact on the Company's outlook for 2010.
Coronary heart disease is the leading cause of death in the U.S., and African Americans are disproportionately affected.
› Verified 1 days ago
Liliane Sarkis Deeb, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 4106 Hylan Blvd, Staten Island, NY 10308 Phone: 718-226-7855 Fax: 718-227-5814 | |
Deepak Vadada, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1050 Clove Rd, Staten Island, NY 10301 Phone: 718-816-6440 Fax: 718-816-3611 | |
Dr. Samantha Maria Lee, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 475 Seaview Ave, Staten Island, NY 10305 Phone: 718-226-9510 Fax: 718-226-3473 | |
Dr. Jean Chalhoub, M.D Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 475 Seaview Avenue, Department Of Internal Medicine, Staten Island, NY 10305 Phone: 718-226-8855 | |
Dr. Gustave Stephen Drivas, M.D., Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 5405 Hylan Blvd, Staten Island, NY 10312 Phone: 718-948-3890 Fax: 718-948-3961 | |
Dr. Beatrice Nogueira, MD Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 475 Seaview Ave, Staten Island, NY 10305 Phone: 718-226-6902 Fax: 718-226-6844 | |
Dr. Felicia Tenedios, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1200 South Ave Ste 204, Staten Island, NY 10314 Phone: 718-447-0055 Fax: 718-876-5212 |